CNE100003PG4
CNE100003PG4
PHARMARON
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 56.22B EUR | 33.53B EUR | 34.58B EUR | 34.78B EUR |
Enterprise Value | 61.2B EUR | 38.91B EUR | 39.3B EUR | 40.8B EUR |
Valuation Multiples | ||||
Trailing P/E | 28.87x | 26.34x | 27.57x | 28.41x |
Forward P/E | 18.26x | -- | -- | -- |
Price to Sales | 3.69x | 2.89x | 3.16x | 3.33x |
Price to Book | 2.93x | 2.05x | 2.1x | 2.31x |
EV/Revenue | 4.01x | 3.35x | 3.6x | 3.9x |
EV/EBITDA | 18.99x | 23.22x | 23.57x | 25.2x |
Price to FCF (P/FCF) | -- | -- | -- | 128.58x |
EV/FCF | -- | -- | -- | 150.85x |
FCF Yield | -2.38% | -0.8% | -0% | 0.78% |